Related Experiment Video
Updated: Jun 28, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Facilitators for practice change in Spanish community pharmacy
Miguel A Gastelurrutia1, S I Charlie Benrimoj, Carla C Castrillon
1Pharmaceutical Care Research Group, University of Granada,Granada, Spain. magastelu@farmanorte.org
Pharmacy World & Science : PWS
|November 11, 2008
Summary
Community pharmacists identified remuneration as key for practice change, while strategists prioritized clinical education and attitude shifts. This study highlights differing views on facilitators for pharmacy practice evolution.
Area of Science:
- Pharmacy Practice and Management
- Healthcare Policy and Research
Background:
- Community pharmacy practice is evolving, necessitating changes to service delivery and professional roles.
- Identifying key facilitators is crucial for successful implementation of practice advancements in Spanish community pharmacies.
Purpose of the Study:
- To identify and prioritize facilitators for practice change within the Spanish community pharmacy setting.
- To understand the perspectives of both community pharmacists and pharmacy strategists on practice change.
Main Methods:
- A qualitative study employing semi-structured interviews with 15 community pharmacists and 18 pharmacy strategists.
- Content analysis of interview data, followed by nominal group discussions to identify and prioritize facilitators.
- Triangulation of data from interviews and nominal groups to ensure robust findings.
Main Results:
- Twelve facilitators for practice change were identified, categorized into four domains: Pharmacist, Pharmacy Organization, Pharmaceutical Profession, and Miscellaneous.
- Key facilitators include enhanced clinical education, clearer professional messaging, improved pharmacist attitudes, revised reimbursement systems for cognitive services, and stronger leadership from professional bodies.
- Other identified facilitators involve reducing administrative workload, bridging the education-research gap, increasing patient demand, improving physician relationships, and better marketing of services.
Conclusions:
- Significant differences exist between community pharmacists and strategists regarding the importance of facilitators.
- Community pharmacists emphasize remuneration as the most critical factor, whereas strategists prioritize clinical education and pharmacist attitudes.
- Addressing these differing perspectives is essential for effective implementation of practice change initiatives in Spanish community pharmacies.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:30Community Based Intervention
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...